Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–3 of 3 results
Advanced filters: Author: Magda Chlebus Clear advanced filters

  • Improved R&D models, supported by appropriate regulatory pathways, are needed to provide new drugs with greater efficiency, in a framework that is financially viable for all stakeholders. Here, we present the perspective of the European Federation of Pharmaceutical Industries and Associations on the key areas on which to focus to achieve this.

    • Susan R. Forda
    • Richard Bergström
    • Peter Høngaard Andersen
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 12, P: 247-248

  • Innovative Medicines Initiative projects focused on translational safety have developed a range of tools to improve preclinical assessments of potential drug toxicities, and demonstrated the value of integrating data from multiple companies.

    • Salah-Dine Chibout
    • Dominique Brees
    • Elisabetta Vaudano
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 24, P: 727-728

  • Since its launch a decade ago, the European Innovative Medicines Initiative (IMI), a leading public–private partnership in life sciences, has catalysed scientific breakthroughs and the development of strategies to address complex challenges in various biomedical fields. Here, we discuss the progress of IMI projects related to vaccine research and development.

    • Philippe Denoel
    • Patricia Londoño-Hayes
    • Magdalena Rodriguez de Azero
    Comments & Opinion
    Nature Reviews Drug Discovery
    Volume: 17, P: 769-770